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A B S T R A C T
The detection of specific chromosomal abnormalities is important in the diagnostic workup of aggressive lymphomas,
giving its impact on the treatment strategies and prognosis. This has been accomplished by using the fluorescent in situ
hybridisation method (FISH) performed on fine needle aspiration (FNA) specimens what is attractive in the diagnosis of
lymphoma in the comparation with other methods for collecting samples. The cytogenetic analyses were performed in se-
ries of 80 patients with lymphoma (43 women and 37 men, median age 48, range 3–90 years). In our series 89.0% (71) of
the specimens yield sufficient numbers of analysable metaphases, comprising 63 non-Hodgkin lymphomas (NHL) and 8
examples of Hodgkin disease (HD). Among 71 successful karyotyped specimens 58 (82.0%) showed clonal karyotypic ab-
normalities. Numerical changes in 4, structural changes in 20 and both and numerical with structural changes in 30 of
54 NHL cases. Trisomies 3, 7, 8, 12, 18, X and monosomies 1 were most common numerical abnormalities. The NHL
cases were typically characterised by structural rather than numerical aberrations with chromosome arms 1p/q, 3p/q, 6q,
11q, 17p and 14q most frequently involved. The expected translocation (14;18)(q32;q21) in 8 and t(8;14)(q24;q34) in 6
cases, both translocations at the same time in three cases, complex rearrangement with chromosome 8, 14, and 18, na-
mely t(8;14;18)(q24;q32;q21) in one case, t(11;14)(q13;q32) in three and one case with translocation 14q32 with chromo-
some 3q27, 6q and 14q32 were found. In 28 of 54 (52%) NHL cases t(14;v) was present. Four abnormal clones detected in
Hodgkin disease were typically consisted of a small percentage of metaphases. The use of FISH method enable the detec-
tion of loss or gain of genetic material and reveal rearrangements unsuspected by conventional cytogenetics in 34 (48.0%)
cases.
Key words: fine needle aspirate, lymphoma, cytogenetics
Introduction
Lymphomas are the group of clinically important
neoplasms with a complex biology, which makes their
classification and treatment difficult. They cause signifi-
cant morbidity and mortality1. The World Health Orga-
nization (WHO) classification based on morphology, im-
munophenotype, genotype, the normal cell counterpart
and clinical behaviour recognizes three main groups
(with multiple subsets): non-Hodgkin lymphoma (NHL)
of B cells and T/natural killer (NK) cells and Hodgkin
disease (HD)2. The B- and T-cell neoplasms are stratified
into precursor (lymphoblastic lymphomas), or lympho-
blastic neoplasms, and mature (peripheral) B- and T-cell
neoplasms3,4. The mature B- and T-cell neoplasms are
grouped according to their major clinical features into
the: predominantly disseminated (leukemic), primarily
extranodal, and predominantly nodal NHL which result
from transformation of B and T/NK cells5. From 75 to
85% of lymphomas are B-cell type1,6. Their hallmark is
chromosomal translocation resulting from aberrant rear-
rangements of immunoglobulin (IG) and T-cell receptor
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(TCR) genes. That leads to an inappropriate expression
of genes at reciprocal breakpoints that regulate a variety
of cellular functions (gene transcription, cell cycle, apo-
ptosis) and tumor progression. Cytogenetics and molecu-
lar genetic analysis of some of the recurring trans-
locations gave new insights into the pathogenesis of
lymphoma, which may play a role in their classifications,
to provide lymphoma progression and clinical beha-
viour1,7,8. Certain lymphoid malignancies harbor a char-
acteristic chromosomal translocation, a finding that may
have significant implications for an individual’s progno-
sis or response to therapy9. B-NHL is characterized by
recurrent translocations involving the immunoglobulin
heavy chain (IGH) gene in approximately 50% of cases6.
The most consistent chromosomal abnormalities in
B-NHL, reciprocal translocations t(11;14)(q13;q32) and
t(14;18)(q32;q21) in mantle cell lymphoma (MCL) and
follicular lymphoma (FL), respectively, are now viewed as
highly specific markers, present in greater than 90% of
the cases10. For example, Burkitt lymphoma (BL), a
highly aggressive lymphoma, is associated with a trans-
location involving c-myc gene in more than 90% of cases.
In over 95% of mantle cell lymphomas (MCL), a t(11;14)
(q13;q32) is found involving the cyclin D1 and IGH
genes. In addition, a translocation of the BCL2 gene to
the IgH gene locus resulting in a t(14;18) is a hallmark of
follicular lymphoma and is only seen in 20–30% of the
diffuse large B cell lymphoma (DLBCL) IGH transloca-
tions11. Chromosomally aberrant clones are rarely de-
tected in HD (20–50% of cases), with relatively simple
chromosome aberrations7. In contrast, cytogenetically
identical translocations may be found in several types of
disease. Chromosomal translocations involving the im-
munoglobulin heavy-chain locus (IGH) are a feature of
mature B-cell malignancies and result in deregulated ex-
pression of the translocated genes due to proximity of
transcriptional enhancers with IGH12. The IGH locus is
located on chromosome 14, at band q32.3 and spans
1,250-kilobase (kb) region5. IG translocations are usually
detected by cytogenetics often supplemented with fluo-
rescence in situ hybridisation (FISH) methods using
probes that span the IG loci13. Previous reports have
shown that FISH can be performed on FNA specimens10,14.
Karyotypes obtained by conventional cytogenetics are
usually complex, with numerous structural abnormali-
ties. Therefore, banding techniques may fail to identify
cryptic translocations or insertions and those partners
located in the terminal bands of other chromosome.
FISH is well-suited to determine the incidence of those
specific translocations in complex karyotype6.
However, there is only limited publishing data regard-
ing the diagnostic utility of FISH-based detection of
these translocations. Cytogenetic analysis, based on ban-
ding techniques, present an overview of all cytogenetic
aberrations. However, lack of success in culturing tu-
mour cells, low mitotic indices and the lack of fresh mate-
rial often complicates the use of this technology for rou-
tine diagnosis11. Interphase FISH has an enhanced ability
over conventional cytogenetics to detect specific chromo-
somal abnormalities14.
We present the results of 80 cases of lymphoma diag-
nosed from the fine needle aspiration (FNA) of lymph
node combining with cytomorphology and cytogenetic
analysis for a definitive diagnosis.
Patients and Methods
Aspirates from 80 patients undergoing diagnostic
FNA for the evaluation of clinically suspected lymphoma
were collected. Of these, 43 were women and 37 were
men, ages 3 to 90, with a median age of 48 years.
Cytomorphological methods
The specimens were obtained using a 23-gauge dis-
posable needle and 10 ml disposable syringe. At each
FNA 5–10 passes in the lymph node were completed. The
aspirate from one or more FNA (depending on sufficient
material) was used for cytomorphological diagnoses. The
material from FNA was immediately smeared onto sev-
eral slides, and air dried smears stained by the May-
-Grünwald-Giemsa method. Cytochemical analysis (mye-
loperoxidase, non-specific esterase, DNA staining) and
imunocytochemical analysis were also performed15–17.
Conventional cytogenetics
The material from one or more FNA was collected
only as a needle and syringe washings in a 10-ml tube
with 2ml RPMI 1640 tissue culture medium and two
drops of heparin solution. This was accomplished by
withdrawing the contents of the tube into the syringe
barrel and gently expelling into the tube and repeating
the procedure at least three times to ensure maximum
recovery of the material until the medium was visibly
cloudy. The lymph node cells were incubated at 37 °C and
cultured for 24 and 48 hours with stimulation with FdU.
After exposing the culture to Colcemid (0.05 g/mL) for
20 minutes the suspensions were resusspended in 0.074
mol/L KCl for 10 minutes and fixed with a 3:1 mixture of
methanol and glacial acetic acid. After repeating the fixa-
tion process three times, the slide preparation was made,
and G-banded with Wright’s stain17,18. All metaphase
plates were analysed, recorded, and saved. Abnormal
clone was defined as two or more cells with the same
structural abnormality or the same extra chromosome,
or the presence of three or more cells with the same miss-
ing chromosome. Case with only one mitotic cell with an
abnormal karyotype, was considered a malignant clone if
there was structural abnormality known to be associated
with lymphoma. When it was possible, it was confirmed
by fluorescent in situ hybridization (FISH)19.
Molecular cytogenetics
FISH was performed using specific DNA probes
(Kreatech, Qbiogene, Vysis) for aneuploidy centromere
probes of chromosome 1–22 and XY and for detection of
specific translocations t(8;14), t(11;14) and t(14;18), re-
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spectively, according to the manufacturer’s instructions
on metaphase and interphase cells. The chromosome
paints and telomeric probes were chosen according to the
chromosomal rearrangment observed in conventional
cytogenetics. FISH signals were analyzed using a AX70
fluorescent microscope (Olympus) equipped with appro-
priate filter sets for observing Spectrum -Green, -Or-
ange, or -Aqua and DAPI signals. Abnormal results were
defined when the percent of cells with any given chromo-
some abnormality exceeded the normal cut-off value of
200 analysed cells. FISH probes were validated using
negative or positive controls. Appropriate positive con-
trols were selected from archival material of patients
with prior cytogenetic evidence of the reciprocal trans-
locations. FISH permitted to detect loss or gain of genetic
material and also reveal rearrangements unsuspected by
conventional cytogenetics6. The karyotypes and FISH re-
sults were described according of the International sys-
tem for Human Cytogenetic Nomenclature 2005 (ISCN
2005)20.
Results
The 80 cases of lymphoma were cytomorphologically
and cytogenetically identified in the FNA material. In
89% (71/80) specimens material was available for classifi-
cation and showed a predominant B-cell lymphoma
(B-NHL) in 75.0% (53), T-cell in 14.0% (10) and Hodgkin
lymphoma (HD) in 11.0% (8) samples (Table 1). Of the 53
cytology specimens of B-NHL’s, 6 were precursor B-cell
lymphoma and 47 mature B-cell lymphoma, including 22
cases of Burkitt lymphoma (BL), 11 cases of diffuse large
B-cell lymphoma (DLBCL), 8 cases of follicular lym-
phoma (FL), 3 cases of mantle cell lymphoma (MCL), 2
cases of extranodal marginal zone B-cell lymphoma of
MALT type (MALT) and one case of lymphoplasmacytic
lymphoma (LPL) (Table 2). Among the 71 successfully
karyotyped specimens, 82.0% (58) showed clonal karyo-
typic abnormalities.
Abnormal karyotype of 53 B-cell NHL’s specimens
showed numerical changes in 7.5% (n=4) cases. Triso-
mies 3, 7, 8, 12, X and monosomy 1 were most common
numerical changes. Structural changes were found in
37% (20/53) cases, while both numerical and structural
changes were discovered in 56.6% (30/53) cases of B-NHL.
Structural aberrations involving chromosome arms 1p/q,
3p/q, 6q, 11q, 17p and 14q were most frequent. An IGH
rearrangement was found in 53% (28/53) cases of B-NHL,
in 20% (2/10) cases of T-NHL and 12.5% (1/8) cases of
HD. Translocation t(8;14)(q24;q34) was found in 28.6%
(4/14) cases of BL and 1% (1/10) case of NHL-T and
12.5% (1/8) cases of HD. Translocation (14;18)(q32;q21)
was found in 62.5% (5/8) cases of FL, 14.3% (2/14) cases
of BL, and 25% (1/4) cases of B-cell NOS. Both trans-
locations, t(8;14)(q24;q34) and (14;18)(q32;q21) were de-
tected in three cases at the same time: 14.3%(2/14) in BL
and 9% (1/11) in DLBCL. Complex rearrangement in-
volving chromosome 8, 14, and 18, namely t(8;14;18)
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TABLE 1
NUMBERS OF DIFFERENT TYPES OF MALIGNANT LYMPHOMA WITH CLONAL CHROMOSOMAL ABNORMALITIES
Cytogenetic results
Cytogenetically abnormal No (%) Cytogenetically normal No
B-cell NHL 53 (75%) 37 (69.8%) 7
T-cell / NKLL 10 (14%) 8 (80%) 2
Hodgkin lymphoma 8 (11%) 4 (50%) 4
Total 71 58 (82%) 13
TABLE 2
NUMBERS OF DIFFERENT SUBTYPES OF B-CELL NON-HODGKIN LYMPHOMA WITH CLONAL CHROMOSOMAL ABNORMALITIES
Cytomorphology No (%) of samples
Cytogenetic results
Cytogenetically abnormal No (%) Cytogenetically normal No
Precursor B-cell neoplasms 6 (11%) 6 –
LPL 1 (2%) 1 –
MALT 2 (4%) 2 –
FL 8 (15%) 6 2
MCL 3 (5.5%) 3 –
DLBCL 11 (21%) 9 2
BL 22 (41.5%) 19 3
Total 53 37 (69.8%) 7
LPL – lymphoplasmacytic lymphoma, MALT – mucosa-associated lymphoid tissue lymphoma (extranodal marginal zone B-cell lym-
phoma), FL – follicular lymphoma, MCL – mantle cell lymphoma, DLBCL – diffuse large B-cell lymphoma, BL – Burkitt lymphoma
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TABLE 3
CYTOMORPHOLOGY AND KARYOTYPE IN SUBTYPES OF MALIGNANT LYMPHOMA
B-cell neoplasms
Precursor B-cell neoplasms
No Age/sex Cytomorphology Cytogenetics
1. 68/M B-cell NOS 46,XY,t(14;18)(q32;q21)[2]/46,XX[10]
2. 67/M B-cell NOS 85–88,XY...inc[3]/46,XY[11]
3. 57/F B-cell NOS 90,XXX,der(9)t(9p;17q) x 2,-17 x 2[8]/46,XX[3]
4. 72/F B-cell 47~49,XX,+3,del(3q),t(9;14)(q21;q11),?add(20p),+mar[cp10]/46,XX[6]
5. 24/F B-cell NOS 46,XX,i(17)(q10) [10]
6. 31/M B-cell 47,XY,+8[15]
Mature B-cll neoplasms
1. 69/F LPL 47,XX,del(5q)+12[2]/46,XX[10]
2. 49/M MALT 49,Y,del(Xp), der(14q32),der(14q32),+18,+mar[5]/46,XY[2]
3. 57/M MALT 47,XY,+?X,der(1)t(1q;10p)del(3)(p21),add(4q),del(7)(q36),-10,?inv(11q), add(13p),
der(19)t(1q;19p),-22,+2mar[cp12]
4. 41/F FL I 46,XX,add(1)(p36)dup(1)(q21),t(14;18)(q32;q21),del(17)(q25)[8]
5. 50/F FL I nuc ish t(14;18)(q32;q21) 10%
6. 66/M FL I 47,XY,t(14;18)(q32;q21),+18[15]
7. 55/M FL I 46,XX,del(4)(q21q2?7),t(14;18)(q32;q21)[8]/46,XX[5]
8. -/F FL II 45,X,-X,-3,+12[12]
9. -/M FL II 47,XY,+2,ins(12;?)(q15;?),t (14;18)(q24;q21)[10]/46,XY[5]
10. 72/F FL II 46,XX[15]
11. -/F FL II 46,XX[10]
12. 55/F MCL 46,XX,t(11;14)(q13;q32)[2]
13. 60/F MCL 47,XX,add(12q),i(17)(q10),+mar[9]/46,XX[5]
14. -/F MCL 45,XX,+7,-9,t(11;14)(q13;q32),-13,der(15)t(?;15)[4]/46,X X[30]
15. 33/F DLBCL 48,XX,i(7q),add(14)(q32),+i(?),+mar[8]
16. -/F DLBCL 46,XX,der(7),t(7p;?)[10]
17. -/M DLBCL 46,XY[10]
18. -/F DLBCL 46,XX,del(5q),der(6)t(1;6)(q23;q27),der(10)t(10;11)(p13-14;q13)
[7]/92,XX[3]/46,XX[3]
19. -/M DLBCL 50,XY,-1,+3,+12,add(14)(q32),add(15)(p11)i(18q),+mar x 2 [3]/46,XY[20]
20. 56/M DLBCL 46,XY,del(6q) [2]/46,XY[30]
21. -/M DLBCL 46,XY,der(11)add(11)(p15)del(11q21)[3]
22. 56/M DLBCL 46,XY[17]
23. 64/F DLBCL 46,XX,t(1p;?),dup(3)(pter?q27qter),t(8;14)(q24;q32),t(14;18)(q32;q21),
t(11q;12q)[15]/46,XX[2]
24. 65/M DLBCL 70,XY,der(Xq),der(1p),-2,add(2q),-3,-6,-6,dic(6;?),+7,-8,-9,add(9p),add(10q),
add(10q), +12,add(16p),add(17q),+19,-22,-22,add(22p),+5mar[1]
25. 55/M DLBCL 46,XY,der(4)t(1;4)(q23;q35)[10]/46,XY[3]ncl:del(1p),i(q)
26. -/M BL like 48,XY,+3,t(11;14)(q13;q32),+12[15]/46,XY[5]
27. -/M BL like 86,XXYY…+3mar,1-2mar, dmin [6]
28. 44/F BL like 46,XX,dup(1)(q21q31),i(7q),t(8;14)(q24;q32)[10]/46X,i(Xq),idem[8]
29. 3/F BL like 46,XX [5]
30. 13/F BL like 46,XX,dup(1q),t(2p;8q),add(7q),del(9q),add(21p)[cp20]
31. 70/F BL like 46,XX,t(2;?;3),dup(5q) [15]/46,idem,del(9p) [2]/47,idem,+mar [3]/46,XX[4]
32. 20/F BL like 49,XX,+7,t(8;14)(q21;32),+ 10,t(14;18)(q32;21),+der(18)t(14;18)(q32;q21) [14]
33. 57/M BL like 48~52,XY,+X,del(1p),+5,del(6q),+7,+12,t(14;18)(q32;q21),+22 [cp9]/46,XY[3]
34. 75/F BL 46,XX,t(2,12)(q21;q22),der(3q),t(6;14)(p21;q32),del(6q),der(8p),add(9p), del(11p),
tas(1;12)(q21;q24),der(14) [cp12]
35. 59/M BL 49,XY,+del(1)(p31),t(2;22)(p12;q11),+7,+8,t(8,14)(q24;q32),t(13;15)(p12;q14),
t(14;18) (q32;q21)[12]/50,idem,+7[8]
(q24;q32:q21) was found in one case BL. Translocation
(11;14)(q13;q32) was found in two cases MCL and one
case BL. The translocation 14q32 with chromosome 3, 6
or 14 was found in 5 cases (MALT, DLBCL x 2 and BL x
2). Abnormal clones in 50.0% (n=4) cases of Hodgkin dis-
ease consisted of a small percentage of metaphases. The




No Age/sex Cytomorphology Cytogenetics
36. -/M BL 46, XY[14]
37. 58/F BL 48,XX,+X,add(11p),t(14;18)(q32;q21),+mar,0-2dmin[11]
38. 90/M BL 46,XY,t(8;14))(q24;32),-21,+der(21)t(1; 21)(q14;p12)[14]
39. -/M BL 49,XY,+X,add(3q),+7,add(11q),+12[15]/ 46,XY[1]
40. 24/F BL 46,XX,der(1),t(1pter;?),-8,+ 11[10]
41. 45/F BL 46, XX,t(8;14)(q24;32) [10]/46,XY[7]
42. 8/M BL 46,XY[9]
43. -/F BL 46,XX,t(3;14)(q27;q32)[2]/46,XX[3]
44. 38/F BL 46,XX,t(8;14)[6]/46,XX[2]
45. 72/F BL 48,X,-X,+3,+ i(6)(p10) x 2,del(6q),del(9p22),del(15q)?7?BM 47,XX,+12?1?
46. 51/F BL 46,XX,add(10)(q26)[4]
47 51 BL 47,XX,del(2p),del(3q),t(8;14;18)(q21;q32;q21),-13+2mar?10?/46,XX ?2?
T-cell and NK-cell neoplasms
1. -/F NHL-T NOS 51,XX,-1,add(4q),add(4q),+7,+8,+10,+2mar[8]/46,XX[5]
2. 54/M NHL-T NOS 46,XY[10]
3. 32/F NHL-T NOS 47,XX,+?17[15]
4. 29/M T-LBL 46, XY,del(6q),-14,+mar [15]/46,XY[5]
5. -/M NHL(T-ANAPLASTIC) 46,XY,del(3p),der(3)add(3p)add(3q),del(6q),der(12)t(1;12)(q21;q24),-13,t(14;14),
der(16); dup(16p),+mar[cp12]
6. 46/F NHL –T NOS 46,XX[16]
7. 19/M T-ALL/LBL 47,XY,+21[25]
8. 35/M T-ALL/LBL I 46,XY[17]
II 46,XY,t(1;4)(p32;p12),t(8;14)(q24;q32)[20]





10. 75/F AITL 54,XX,+X,+X,+2,+5,+7,+12,del(12p),+17,+21[2]/46,XX[20]
Hodgkin lymphoma
1. -/F HL 51,X,del(Xq),dup(1)(q25q32), +3,+3,
t(4;11)(q21;q23),+der(11)t(4;11),t(8;14)(q24;q32), +mar1,+mar2[10]/46,XX[8]
2. 40/M HL 46,XY[6]
3. 72/F HL 46,XX[10]
4. 72/F HL 46,X,?-X,del(3)(q21),+12[2]/47,XX,+mar[1]/46,XX[15]
BM 47,XX,-1,+5,+mar[2]/46,XX[20]
5. -/M HL 1995-46,XY[4]
2006-46,XY[10]
6. 43/M HL-LP 45,XY,dic(13;15)[15]
7. 57/M HL/ALCL 46,XY[20]
8. 72/F HL 46,X,-?X,del(3)(q21),+12[2]/46,XX[5]
BM 47,XX,+r(12)[1]
NHL – non-Hodgkin lymphoma, LPL – lymphoplasmacytic lymphoma, MALT – mucosa-associated lymphoid tissue lymphoma (extra-
nodal marginal zone B-cell lymphoma), FL – follicular lymphoma, MCL – mantle cell lymphoma, DLBCL – diffuse large B-cell lym-
phoma, BL – Burkitt lymphoma, HL –Hodgkin lymphoma, LP – lymphocytic predominance, ALCL – anaplastic large cell lymphoma,
AITL – angioimmunoblastic T-lymphoma, NOS – not otherwise specified, T-ALL/LBL – T-lymphoblastic leukemia/lymphoblastic lym-
phoma
various chromosomal translocations in lymphoma are re-
viewed below according to cytologic subtype of disease
(Table 3).
FISH detected breakpoints, loss or gain of genetic ma-
terial and revealed rearrangements unsuspected by con-
ventional cytogenetics like case with t(8;14;18) and in
cases with low mitotic index, namely in 34 (48%) of them.
Discussion and Conclusion
Recurrent chromosomal translocations are important
diagnostic and prognostic markers contributing to the
management of patients with a variety of hematologic
malignancies13. While the acute leukemias are associated
with only a single chromosomal translocation, malignan-
cies of mature B cells often exhibit enormous cytogenetic
complexity, with multiple and complex translocations,
deletions, and amplifications in the 1 clone21,22. Func-
tional consequence of gene dysregulation in lymphoid
lineage development and lymphomagenesis may be
caused by juxtaposition of homeobox (Hox) genes with
imunoglobulin heavy chain gene IGH5,23. Specific chro-
mosomal translocations are closely associated with dis-
tinctive subtypes of non-Hodgkin lymphoma. Activation
of BCL2 (18q21) and MYC (8q24) oncogenes usually oc-
curs in B-cell non-Hodgkin lymphoma by translocation
to IGH (14q32) allele4,22,23. Cytogenetic findings in lym-
phomas might be helpful in understanding pathogenesis
of those disorders24–26.
The aim of the current study was to determine whe-
ther conventional and molecular cytogenetics studies im-
proved the ability to diagnose and/or subclassify B-cell
NHL, T-cell NHL and HD on FNA. By incorporating the
results of conventional cytogenetic and FISH, a defini-
tive classification was reached in 53 cases of B-cell NHL,
10 T-cell NHL and 8 cases of HD according to their
cytomorphologic diagnosis and abnormal karyotypes. Ty-
pes of chromosomal abnormalities are similar to those
reported in the literature where material was either
lymph-node specimens and/or bone marrow biopsy sec-
tions. In 82% (58/71) patients with diagnosed lymphoma,
the karyotypes showed one or more abnormalities. In
54% (28/54) NHL cases t(14;v) was present. Major recur-
rent clonally chromosomal changes were structural ra-
ther than numerical aberrations, involving chromosome
14q32 and chromosome arms 1p/q, 3p/q, 6q, 11q, 17p.
Trisomies 3, 7, 8, 12, X and monosomy 1 were also pres-
ent. Characteristic translocations were t(8;14) found in
six cases and t(14;18) found in eight cases, both trans-
locations at the same time were found in three cases,
t(11;14) in three and one case with translocation 14q32
with chromosome 3, 6 and 14. Complex rearrangement
including chromosome 8, 14, and 18 in one case, with
concurrent activation of BCL2 and MYC by translocation
of both oncogenes to both IGH alleles. Abnormal clones
containing discrete chromosome aberrations, with a small
percentage of metaphases were found in four (50.0%)
cases of HD. This yield of abnormal metaphases in NHL
and HD is comparable to previous studies5,14,15.
This study illustrate the utility of cytogenetic analysis
as an additional ancillary technique to improve the diag-
nosis and classification of lymphoma. By using FNA, we
have shown that 89% of specimens presented recurrent
chromosomal abnormalities. With proper handling and
management of specimens, FNA can routinely provide
samples adequate for molecular genetic studies, in addi-
tion to cytomorphology, making it possible to consis-
tently render accurate and primary diagnoses in a subset
of NHL’s. Moreover, some cytogenetic alterations define
clinically relevant subgroups and are, therefore, crucial
for therapy decisions.
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U^ESTALE KROMOSOMSKE ABNORMALNOSTI U LIMFOMIMA, UZORCI DOBIVENI
CITOLO[KOM PUNKCIJOM LIMFNOG ^VORA TANKOM IGLOM
S A @ E T A K
Otkrivanje kromosomskih abnormalnosti u limfomima va`no je u postavljanju dijagnoze agresivnih limfoma te do-
prinosi strategiji lije~enja i prognozi. U posljednjih nekoliko godina je fluorescentna in situ hibridizacijska metoda
(FISH) neizostavna dopuna evaluaciji malignih hematolo{kih bolesti, a na uzorcima dobivenim citolo{kom punkcijom
limfnog ~vora (FNA) u usporedbi s drugim metodama i vrlo izazovna metoda u dijagnostici limfoma. Ovaj rad obra|uje
citogenetsko istra`ivanje 80 pacijenata s limfomom (od kojih su 43 `ene a 37 mu{karci, prosje~ne dobi 48, u rasponu od
3 do 90 godina starosti). U na{oj skupini u 89% (n=71) uzoraka je bio dovoljan broj metafaza podobnih za analizu, a
~inili su ga 63 primjera Non-Hodgkinovog sindroma (NHL) i 8 primjera Hodgkinove bolesti (HD). Od 71 uspje{no
kariotipiziranih uzoraka 82,0% (58) je slu~ajeva pokazalo klonalne kariotipske abnormalnosti. Numeri~ke promjene u 4
od 53 slu~aja NHL-a i numeri~ke te strukturne promjene u 51 od 53 slu~aja NHL-a. Od numeri~kih promjena su triso-
mije 3, 7, 8, 12, 18, X i monosomija 1 bile naju~estalije. Slu~ajeve NHL-a uglavnom obilje`avaju u~estalije strukturne
nego numeri~ke aberacije s naj~e{}im kromosomom 1p/q, 3p/q, 6q, 11q, 17p i 14q. O~ekivano, t(14;18)(q32;q21) u 8 i
t(8;14)(q24;q34) u 6 slu~ajeva a obje su se translokacije pojavile u isto vrijeme u tri slu~aja dok je kompleksni re-
aran`man s kromosomima 8, 14 i 18, poglavito t(8;14; 18)(q24;q32;q21) u jednom slu~aju, t(11;14)(q13;q32) u tri
slu~aja i jedan slu~aj s translokacijom 14q32 s kromosomima 3, 6 i 14. U 24 od 64 (37,5%) slu~ajeva NHL-a bila je
prisutna t(14;v). ^etiri abnormalna klona otkrivena su u HD i obi~no su sastojali od malog postotka metafaza. Primjena
tehnike FISH omogu}ila je otkrivanje gubitka ili vi{ka genetskog materijala i preuredbe gena koje se nisu o~ekivali
klasi~nom citogenetikom u 34 (48%) slu~aja.
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